Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 299, 113873
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Safety of long-term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: Two cross-sectional, naturalistic studiesAustralian & New Zealand Journal of Psychiatry, 2013
- Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experienceAustralasian Psychiatry, 2013
- A New Monitoring Protocol for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 ControlsAustralian & New Zealand Journal of Psychiatry, 2011
- Estimating the Prevalence of Schizophrenia Among New Zealand Māori: A Capture–Recapture ApproachAustralian & New Zealand Journal of Psychiatry, 2008
- Contemporary Definitions and Classification of the CardiomyopathiesCirculation, 2006
- Clozapine and Heart in the Hunter RegionAustralian & New Zealand Journal of Psychiatry, 2006
- Clozapine-Related Myocarditis and Cardiomyopathy in an Australian Metropolitan Psychiatric ServiceAustralian & New Zealand Journal of Psychiatry, 2004
- ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary ArticleCirculation, 2003
- Myocarditis and Cardiomyopathy Associated with Clozapine Use in the United StatesNew England Journal of Medicine, 2001
- Diagnosis and management of dilated cardiomyopathyHeart, 2000